TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has completed in the randomized cohort of the Phase 3 ENHANCE trial evaluating a consolidated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback